Drug-Eluting or Bare Metal Stents for the Treatment of Saphenous Vein Graft Disease | Zendy

JeanMichel Paradis | Zendy; Patrick Bélisle | Zendy; Lawrence Joseph | Zendy; Olivier F. Bertrand | Zendy; Robert DeLarochellière | Zendy; JeanPierre Déry | Zendy; Éric Larose | Zendy; Josep RodésCabau | Zendy; Stéphane Rinfret | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drug-Eluting or Bare Metal Stents for the Treatment of Saphenous Vein Graft Disease

Author(s) -

JeanMichel Paradis,

Patrick Bélisle,

Lawrence Joseph,

Olivier F. Bertrand,

Robert DeLarochellière,

JeanPierre Déry,

Éric Larose,

Josep RodésCabau,

Stéphane Rinfret

Publication year - 2010

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.110.949735

Subject(s) - medicine , odds ratio , randomized controlled trial , myocardial infarction , revascularization , stent , surgery , observational study , meta analysis , cardiology , drug eluting stent , adverse effect , confidence interval , statin , restenosis , coronary artery disease

Observational studies and randomized, controlled trials have yielded uncertain results regarding the benefits of drug-eluting stents (DES) for the treatment of saphenous vein graft (SVG) disease. The objective of this meta-analysis was to assess the cumulative evidence regarding the efficacy and effectiveness of DES to treat SVG compared with bare metal stent (BMS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research